Healthcare tech company GoodRx (NASDAQ:GDRX) will report earnings after the bell this Wednesday. Last quarter, GoodRx beat revenue expectations with $196 million, flat year on year, but missed EPS estimates. It lost -300,000 customers and now has 5.4 million total. Analysts expect a 2.7% revenue decline this quarter. Peers like Tandem Diabetes and Hims & Hers Health reported positive results, hinting at what to expect. GoodRx has seen share prices drop 9.1% in the last month amid market volatility. Analysts have an average price target of $4.56. Interested in AI stocks? Check out our free analysis.

Read more at StockStory: GoodRx (GDRX) Reports Earnings Tomorrow: What To Expect